The new Pharma ratings for 2022 have just been released by RealRate.
Online PR News – 08-November-2022 – Berlin – These are the top three US Pharma companies with best financial health, measured by Economic Capital Ratio:
1. AGIOS PHARMACEUTICALS – 1002.04%
2. OVID THERAPEUTICS – 665.35%
3. OMEROS – 506.44%
The complete rating of 475 companies is published at: https://realrate.ai/rankings/
A fairly recent player in the pharmaceutical industry, Agios Pharmaceuticals was founded in 2008 and is headquartered in Cambridge, Massachusetts. They are a pioneering leader in cellular metabolism. Ovid Therapeutics is even newer, being founded in 2014 and based out of New York. They’re a biotech company supplying products to those affected by rare neurological diseases. Omeros are the oldest company of the three, being founded in 1994 and are a Seattle-based company specialising in small-molecule and protein therapeutics. The three companies went from 206th, 350th and 319th places in 2021 respectively, so a massive rise for all three.
CEO Dr. Holger Bartel: "The pharmaceutical market in the United States is enormous, accounting for approximately 45% of the global market, and around 22% of production globally. U.S. pharmaceuticals output and sales remain strong during 2022, largely driven by the continuing global vaccination rollout, and also huge demand for both essential and non-essential medical treatments.”
RealRate is an international rating agency based in Santa Clara and Berlin, founded in 2021. Using cutting edge explainable Artificial Intelligence, we provide fair company ratings avoiding any conflict of interest. Combing AI and expert knowledge, financial strength is evaluated based on the published annual reports. RealRate provides rankings for dozens of industries, like insurance, IT, real estate, food and pharma. Only the best rated companies are awarded with the RealRate seal of approval.